Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03020121 · ClinicalTrials.gov registry record · NA
Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples
A NA study, sponsored by Becton, Dickinson and Company.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03020121 is a NA study that was terminated before completion, run by Becton, Dickinson and Company. The registered enrollment target is 28 participants.
The verdict
NCT03020121, a NA study, was terminated before completion, sponsored by Becton, Dickinson and Company.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the results of the Becton Dickinson (BD) Human Papilloma Virus (HPV) Assay on the Viper LT instrument from Liquid-based cytology media diluted in HPV diluent to adjudicated histology results from biopsy.
Interventions
- PROCEDURE Colposcopy/biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03020121
The ClinicalTrials.gov registry entry for NCT03020121 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Colposcopy/biopsy is the first listed.
NCT03020121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03020121 about?
NCT03020121 is a clinical study titled "Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples". The purpose of the study is to compare the results of the Becton Dickinson (BD) Human Papilloma Virus (HPV) Assay on the Viper LT instrument from Liquid-based cytology media diluted in HPV diluent to adjudicated histology results from biopsy.
What is the current status of trial NCT03020121?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2016-11. Estimated completion is 2017-05.
What interventions are being tested in trial NCT03020121?
The interventions under investigation include: Colposcopy/biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03020121?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.